Skip to main content

Research Repository

Advanced Search

An evaluation of a price transparency intervention for two commonly prescribed medications on total institutional expenditure: a prospective study

Langley, Tessa; Lacey, Julia; Johnson, Anthony; Newman, Clive; Khare, Milind; Skelly, Rob; Subramanian, Deepak; Norwood, Mark; Sturrock, Nigel; Fogarty, Andrew W.

An evaluation of a price transparency intervention for two commonly prescribed medications on total institutional expenditure: a prospective study Thumbnail


Authors

Julia Lacey

Anthony Johnson

Clive Newman

Milind Khare

Rob Skelly

Deepak Subramanian

Mark Norwood

Nigel Sturrock

Dr ANDREW FOGARTY ANDREW.FOGARTY@NOTTINGHAM.AC.UK
CLINICAL ASSOCIATE PROFESSOR & READER IN CLINICAL EPIDEMIOLOGY



Abstract

Importance: Providing cost feedback has been demonstrated to decrease demand from clinicians.
Objective: We tested the hypothesis that providing the cost of drugs to clinicians would modify total expenditure.
Design: A prospective study design with a step-wise intervention.
Setting/Participants: Individuals who were admitted to the XXX from November 2013 to November 2015 under the physicians.
Intervention: The cost of all antibiotics and inhaled corticosteroids was added to the electronic prescribing system.
Main outcomes: The weekly cost for antibiotics and inhaled corticosteroids in the intervention period compared to baseline.
Results: Mean weekly expenditure on antibiotics per patient decreased by £3.75 (95% confidence intervals CI: -6.52 to -0.98) after the intervention from a pre-intervention mean of £26.44, and then slowly increased subsequently by £0.10/week (95%CI: +0.02 to +0.18). Mean weekly expenditure on inhaled corticosteroids per patient did not substantially change after the intervention (-£0.03, 95%CI: -0.06 to -0.01 after the intervention from a pre-intervention mean of £5.29 per person).
New clinical guidelines for inhaled corticosteroids were associated with a decrease in weekly expenditure.
Conclusions and relevance: Provision of cost feedback resulted in no sustained change in institutional expenditure. However, clinical guidelines have potential for modifying clinical prescribing behaviour.

Citation

Langley, T., Lacey, J., Johnson, A., Newman, C., Khare, M., Skelly, R., Subramanian, D., Norwood, M., Sturrock, N., & Fogarty, A. W. (2018). An evaluation of a price transparency intervention for two commonly prescribed medications on total institutional expenditure: a prospective study. Future Hospital Journal, 5(3), 198-202. https://doi.org/10.7861/futurehosp.5-3-198

Journal Article Type Article
Acceptance Date Mar 23, 2018
Online Publication Date Oct 4, 2018
Publication Date Oct 1, 2018
Deposit Date May 25, 2018
Publicly Available Date Oct 1, 2018
Journal Future Hospital Journal
Print ISSN 2055-3323
Electronic ISSN 2055-3331
Publisher Royal College of Physicians
Peer Reviewed Peer Reviewed
Volume 5
Issue 3
Pages 198-202
DOI https://doi.org/10.7861/futurehosp.5-3-198
Keywords cost feedback, antibiotics, inhaled corticosteroids
Public URL https://nottingham-repository.worktribe.com/output/921460
Publisher URL http://futurehospital.rcpjournal.org/content/5/3/198
Additional Information This paper has been accepted for publication by the Future Hospital journal and is due for publication in October 2018.

Copyright is retained by the Royal College of Physicians
Contract Date May 25, 2018

Files





You might also like



Downloadable Citations